FDA Inspection 1255480 — Takeda Manufacturing Italia SPA
The FDA completed an inspection of Takeda Manufacturing Italia SPA on November 12, 2024 in Cittaducale. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 12, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Cittaducale (Italy)